SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
----------------------------------
Date of report (Date of earliest event reported): July 27, 2004 (July 27, 2004)
DOV Pharmaceutical, Inc.
(Exact name of registrant as specified in charter)
Delaware 000-49730 22-3374365
(State or other jurisdiction (Commission file number) (IRS employer
of incorporation) identification no.)
433 Hackensack Avenue, Hackensack, NJ 07601
(Address of principal executive offices) (Zip code)
(201) 968-0980
(Registrant's telephone number, including area code)
Item 5. Other Events and Required FD Disclosure.
On July 27, 2004, registrant is holding its 2nd Annual Science Day at the
Millennium Broadway Hotel in New York City. Presenters at the event will use the
slides included as an exhibit to this filing. The event had been announced by
press release dated July 14, 2004, also included as an exhibit. As noted on the
release, a slide and audio transmission of the event will be included on
registrant's website, www.dovpharm.com, for 30 days.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits. The following exhibits are furnished herewith:
Exhibit
Number Title
- ------ -----
99.1 Slides used by presenters at registrant's 2nd Annual Science Day,
July 27, 2004
99.2 Press release dated July 14, 2004, issued by registrant
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
DOV Pharmaceutical, Inc.
Date: July 27, 2004 /s/ Arnold Lippa
----------------
Arnold Lippa
Chief Executive Officer
EXHIBIT INDEX
Exhibit
Number Title
- ------ -----
99.1 Slides used by presenters at registrant's 2nd Annual Science Day
99.2 Press release dated July 14, 2004, issued by registrant